Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Sodium chloride + potassium chloride + magnesium chloride + sodium acetate + sodium gluconate** is a balanced, isotonic multi-electrolyte intravenous crystalloid solution marketed as Plasma-Lyte A, Plasma-Lyte 148, and Isolyte S. It provides water plus sodium, potassium, magnesium, chloride, acetate, and gluconate for intravascular and extracellular fluid replacement and correction of electrolyte losses. Acetate and gluconate are metabolizable anions that consume hydrogen ions during metabolism, producing a metabolic alkalinizing effect. The solution is used for hydration and as a source of water and electrolytes, including in dehydration and electrolyte imbalance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium chloride + potassium chloride + magnesium chloride + sodium acetate + sodium gluconate.